GENERVON
Live / Registered — Registered — Section 8 accepted (as of 15 Oct 2021)
What this means for you
Registered since 10 Nov 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86658545
- Registration number
- 4851428
- Mark type
- Design + words
- Filed
- 10 Jun 2015
- Published for opposition
- 25 Aug 2015
- Registered
- 10 Nov 2015
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for central nervous system disorders and peripheral nervous system disorders; Therapeutic pharmaceutical for the treatment of Amyotrophic Lateral Sclerosis
Owner
- Genervon Biopharmaceuticals, LLC, Pasadena, CA, US
- Genervon Biopharmaceuticals, LLC, Pasadena, CA, US
- Genervon Biopharmaceuticals, LLC, Pasadena, CA, US
Prosecution history
- 10 Nov 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 15 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 15 Oct 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 15 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Jun 2021 — TEAS SECTION 8 RECEIVED
- 10 Nov 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Nov 2015 — REGISTERED-PRINCIPAL REGISTER
- 25 Aug 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Aug 2015 — PUBLISHED FOR OPPOSITION
- 05 Aug 2015 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jul 2015 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 15 Jul 2015 — ASSIGNED TO LIE
- 30 Jun 2015 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jun 2015 — EXAMINER'S AMENDMENT ENTERED
- 30 Jun 2015 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED